customer service software
0

Global Immunotherapy Drugs Market Size Study, by Type of Drugs (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others) by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) by End-Use (Hospitals, Clinics, Others) by Regional Forecasts 2018-2025

  • Published Date: 15 May 2019
  • Number of Pages: 200
  • Category: Pharmaceuticals
  • Country: Global

"Global immunotherapy drugs market is valued approximately USD billion in 2017 and is anticipated to grow with a healthy growth rate of more than 15.2% over the forecast period 2018-2025. Key driving factors of the market are increasing prevalence of life-style oriented diseases, early drug approval processes coupled with increasing adoption of targeted therapies. However, high cost of treatment is expected to hamper the market growth over the forecast period. Increasing prevalence of cancer is one of the significant factors which is driving global immunotherapy drugs market during the forecast period. According to the World Cancer Report, Cancer rates are expected to increase by 50% in the year 2020 reaching a total of 15 million patients.

Regionally, the global immunotherapy market is dominated by North America region valued about $45.9 billion in 2017 that is estimated to reach about $115.9 billion by 2025. North America is followed by Europe, holding the second highest position in global immunotherapy drugs market with 29.0 billion revenues in 2016. These regions account for the highest prevalence of cancer. Furthermore, increasing number of clinical trials and drug approvals in these regions are fueling the market growth. The growth of European market is driven by increasing R&D investments from both public and private sectors. Furthermore, significant growth in drug approvals by European Medicines Agency and strong presence of key players is driving the market growth. However, Asia Pacific is anticipated to grow at the highest CAGR of 18.0% over the forecast period. Rising prevalence of cancers and extensive R&D towards the development of low-cost treatment is anticipated to drive significant opportunities in the APAC immunotherapy drugs market.


On the basis of end-use, the global immunotherapy drugs market is segmented into hospitals, clinics and others. Currently, hospitals segment holds the largest revenue share. Global immunotherapy drugs market in hospitals valued at USD 68.3 billion in 2017 and is anticipated to reach USD 202.3 billion by 2025 growing at a CAGR of 14.5%.

Market player included in this report are:
F.Hoffmann-LA Roche AG
Merck & Co., Inc.
Novartis International AG
Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)
GlaxoSmithKline PLC
Amgen Inc.
AbbVie
AstraZeneca
Bristol-Mysers Squibb
ELI Lilly & Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Drugs:

Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Other Drugs

By Therapy Area:

Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Other Therapy Area


By End-Use:

Hospitals
Clinics
Other End Users



By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors"
 

Publisher Name : Bizwit Research & Consulting LLP

"

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Million)
1.3.1. Immunotherapy Drugs Market, by Type, 2015-2025 (USD Million)
1.3.2. Immunotherapy Drugs Market, by Therapy Area, 2015-2025 (USD Million)
1.3.3. Immunotherapy Drugs Market, by End-use, 2015-2025 (USD Million)
1.3.4. Immunotherapy Drugs Market, by Region, 2015-2025 (USD Million)
1.4. Estimation Methodology
1.5. Research Assumption


Chapter 2. Global Immunotherapy Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates


Chapter 3. Global Immunotherapy Drugs Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities


Chapter 4. Global Immunotherapy Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion


Chapter 5. Global Immunotherapy Drugs Market, by Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Immunotherapy Drugs Market, Sub Segment Analysis
5.3.1. Monoclonal Antibodies
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
5.3.2. Adult Vaccines
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
5.3.3. Checkpoint Inhibitors
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
5.3.4. Interferons Alpha & Beta
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
5.3.5. Interleukins
5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
5.3.6. Others Drugs
5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Million)
5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)


Chapter 6. Global Immunotherapy Drugs Market, by Therapy Area
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Immunotherapy Drugs Market, Sub Segment Analysis
6.3.1. Cancer
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
6.3.2. Autoimmune & Inflammatory Diseases
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
6.3.3. Other Therapy Areas
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)


Chapter 7. Global Immunotherapy Drugs Market, by End-use
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Immunotherapy Drugs Market, Sub Segment Analysis
7.3.1. Hospital
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
7.3.2. Clinics
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)
7.3.3. Other
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Million)


Chapter 8. Global Immunotherapy Drugs Market, by Regional Analysis
8.1. Immunotherapy Drugs Market, Regional Market Snapshot (2015-2025)
8.2. North America Immunotherapy Drugs Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.2.1.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.2.1.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.2.2.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.2.2.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3. Europe Immunotherapy Drugs Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3.1.3. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3.1.4. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3.2. Rest of Europe
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3.2.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.3.2.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4. Asia Immunotherapy Drugs Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.1.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.1.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.2.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.2.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.3.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.3.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.4.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.4.4.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5. Latin America Immunotherapy Drugs Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5.1.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5.1.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5.2.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.5.2.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6.1.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6.1.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Million)
8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6.2.3. Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Million)
8.6.2.4. End-use breakdown estimates & forecasts, 2015-2025 (USD Million)


Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F.Hoffmann-LA Roche AG
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Merck & Co., Inc.
9.3.3. Novartis International AG
9.3.4. Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)
9.3.5. GlaxoSmithKline PLC
9.3.6. Amgen Inc.
9.3.7. AbbVie
9.3.8. AstraZeneca
9.3.9. Bristol-Mysers Squibb
9.3.10. ELI Lilly & Company


Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption"
 



List Of Tables

"
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF IMMUNOTHERAPY DRUGS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF IMMUNOTHERAPY DRUGS MARKET
TABLE 3. IMMUNOTHERAPY DRUGS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD MILLION)
TABLE 7. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD MILLION)
TABLE 8. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 9. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 10. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 11. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 12. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 13. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 14. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 15. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 16. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 17. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 18. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 19. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 20. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 21. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 22. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 23. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 24. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 25. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 26. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 27. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 28. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 29. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 30. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 31. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 32. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 33. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 34. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 35. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 36. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 37. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 38. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 39. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 40. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 41. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 42. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 43. IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 44. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 45. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 46. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 47. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 48. U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 49. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 50. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 51. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 52. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 53. CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 54. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 55. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 56. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 57. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 58. UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 59. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 60. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 61. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 62. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 63. GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 64. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 65. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 66. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 67. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 68. ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 69. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 70. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 71. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 72. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 73. CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 74. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 75. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 76. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 77. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 78. INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 79. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 80. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 81. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 82. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 83. JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 84. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 85. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 86. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 87. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 88. ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 89. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 90. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 91. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 92. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 93. BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 94. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 95. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 96. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 97. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 98. MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 99. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 100. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 101. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 102. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 103. ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 104. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD MILLION)
TABLE 105. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 106. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 107. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)
TABLE 108. ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD MILLION)"
 



List Of Figures

"
FIG 1. IMMUNOTHERAPY DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2. IMMUNOTHERAPY DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. IMMUNOTHERAPY DRUGS MARKET, KEY TRENDS 2016
FIG 5. IMMUNOTHERAPY DRUGS MARKET, GROWTH PROSPECTS 2017-2025
FIG 6. IMMUNOTHERAPY DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7. IMMUNOTHERAPY DRUGS MARKET, PEST ANALYSIS
FIG 8. IMMUNOTHERAPY DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 10. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 11. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 12. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 13. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 14. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 15. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 16. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 17. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 18. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 19. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 20. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 21. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 22. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 23. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 24. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 25. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 26. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 27. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 28. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 29. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 30. IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2015 & 2025 (USD MILLION)
FIG 31. IMMUNOTHERAPY DRUGS MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32. NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET 2015 & 2025 (USD MILLION)
FIG 33. EUROPE IMMUNOTHERAPY DRUGS MARKET 2015 & 2025 (USD MILLION)
FIG 34. ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET 2015 & 2025 (USD MILLION)
FIG 35. LATIN AMERICA IMMUNOTHERAPY DRUGS MARKET 2015 & 2025 (USD MILLION)
FIG 36. IMMUNOTHERAPY DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
"
 



Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2019 GlobalDatas clinical trial report, Degenerative Spondylolisthesis Global Clinical Trials Review, H1, 2019 provides an overview of Degenerative Spondylolisthesis clinical trials scenario. This report

View Report

Degenerative Scoliosis Global Clinical Trials Review, H1, 2019 GlobalDatas clinical trial report, Degenerative Scoliosis Global Clinical Trials Review, H1, 2019 provides an overview of Degenerative Scoliosis clinical trials scenario. This report

View Report

Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2019 GlobalDatas clinical trial report, Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2019 provides an overview of Deep Vein Thrombosis

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)